Biogen's Aduhelm Sales Total $2 Million in Second Quarter

The drug from Biogen, called Aduhelm, is expected to generate billions in sales. It could also strain Medicare’s budget within a few years.

Rebecca Robbins
Author: Rebecca Robbins

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *